Historical record - last NADAC publication: 7/31/2015

Product Information

CUPRIMINE 250 MG CAPSULE is a brand product labeled by Bausch Health US LLC, priced at $255.8478 per EA under NDC 25010070515. Its NADAC has been published 139 times since Dec 18, 2013.

The High Outlier badge above means this manufacturer's average price in the penicillamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CUPRIMINE 250 MG CAPSULE

penicillamine
$255.8478per EA
High Outlier

Strength

250 mg/1

NDC

25010070515

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

7/31/2015

Active Ingredients

PENICILLAMINE

Approval Type

New Drug (NDA)

FDA Application

NDA019853

On Market Since

12/4/1970

Pharmacological Classes

Price Statistics

The NADAC for CUPRIMINE 250 MG CAPSULE has been published 139 times since Dec 18, 2013, and over the history we have for it it has risen 1007.6%. The table below summarizes its recorded NADAC range and movement.

Current price$255.8478 per EA
All-time high$255.8478 (Aug 10, 2016)
All-time low$23.0996 (Dec 18, 2013)
Median price$59.4995
Average price$126.6151
Largest weekly change+300.0% (Aug 12, 2015)
Weeks tracked139
Tracking sinceDec 18, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+1007.6%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 96%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CUPRIMINE 250 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CUPRIMINE 250 MG CAPSULE, manufactured by Bausch Health US LLC, is $255.8478 per EA (NDC 25010070515), effective Aug 10, 2016.

How has the price of CUPRIMINE 250 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CUPRIMINE 250 MG CAPSULE has risen 1007.6%. It has been tracked across 139 weekly CMS publications since Dec 18, 2013.

What are the highest and lowest recorded NADAC prices for CUPRIMINE 250 MG CAPSULE?

Since Dec 18, 2013, the NADAC for CUPRIMINE 250 MG CAPSULE has ranged from a low of $23.0996 (Dec 18, 2013) to a high of $255.8478 (Aug 10, 2016), with a median of $59.4995 per EA.

Are there cheaper alternatives to CUPRIMINE 250 MG CAPSULE?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PENICILLAMINE 250 MG CAPSULE, is $9.2914 per EA — about 96% below CUPRIMINE 250 MG CAPSULE.

Who manufactures CUPRIMINE 250 MG CAPSULE?

CUPRIMINE 250 MG CAPSULE (NDC 25010070515) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.